Sign up with:
Wow, this is quite big news on $CYDY!
You left out biotechs. $CYDY is due to report on their study early next month and it looks more than promising. Sadly it is running up, but it is a small cap trying to move to the big board, so it has a lot more to run.
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Wow, this is quite big news on $CYDY!
Top 3 Industries Benefiting The Most From COVID-19 Pandemic
You left out biotechs. $CYDY is due to report on their study early next month and it looks more than promising. Sadly it is running up, but it is a small cap trying to move to the big board, so it has a lot more to run.